Status:

ACTIVE_NOT_RECRUITING

Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness

Lead Sponsor:

University of Maryland, Baltimore

Conditions:

Prostatic Neoplasm

Survivorship

Eligibility:

All Genders

55+ years

Phase:

PHASE1

PHASE2

Brief Summary

Frailty is one of the main reasons older adults lose independence. Frailty describes a reduced ability to withstand stress on the physiological scale, or a reduced physiological reserve. The theory is...

Detailed Description

Frailty affects more than 5.4 million people over the age of 65 in the United States (\>10%) and is one of the main reasons older adults lose independence. Frailty describes a reduced ability to withs...

Eligibility Criteria

Inclusion

  • Inclusion criteria (Participants must…)
  • Have a diagnosis of prostate cancer or breast cancer
  • Be undergoing hormone therapy (e.g., androgen deprivation therapy)
  • Be 55 years old or older
  • Speak and/or read English
  • Exclusion criteria (Participants must not…)
  • Be on active chemotherapy or radiation for cancer
  • Be underweight (≤18.5 kg/m2)
  • Have lost more than 10 pounds unintentionally in the last 12 months
  • Have surgery planned during the study duration
  • Have had a major surgery, including hip/knee surgery, in the last 3 months
  • Have documented advanced liver, heart, or lung disease
  • Have any contraindications to the proposed nutrition intervention as identified by their medical provider, their designee, or the study team (e.g., type 1 diabetes, risk for hypoglycemia, medication requirements, recent history of an eating disorder, on artificial nutrition)
  • Already eat all their food in a window that is 10 h or shorter on most (6/7) days of the week

Exclusion

    Key Trial Info

    Start Date :

    January 29 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2027

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT05968144

    Start Date

    January 29 2024

    End Date

    December 31 2027

    Last Update

    May 1 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Maryland, Baltimore

    Baltimore, Maryland, United States, 21201

    Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness | DecenTrialz